CANOPY GROWTH CORP COM NPV (OTCMKTS:TWMJF) climbed in early trading today, and has been a rocket since early June. TWMJF is a company with big ambitions and has certainly demonstrated their gusto this month. The microcap cannabis player is up 22% this month and continuing to climb.
TWMJF has experienced huge growth over the past year recently expanding its Tweed Farms to over 1,000,000 sq. ft. of greenhouse space under glass. TWMJF has seen a spectacular swing over the past few years from well under the $2 mark back in 2015 to all-time highs in November of $14.39.
CANOPY GROWTH CORP COM NPV (OTCMKTS:TWMJF) is one of the bigger growers. The company produces and sells medical marijuana in Canada. It offers dry cannabis and oil products primarily under the Tweed and Bedrocan brands. It also sells its products through online.
According to company materials, “Tweed is the most recognized marijuana production brand in the world. It has built a large and loyal following by focusing on quality products and meaningful customer relationships. Tweed doesn’t just sell marijuana, it facilitates a conversation about a product we’ve all heard about but haven’t met intimately yet. It is approachable and friendly, yet reliable and trusted. As marijuana laws liberalize around the world, Tweed will expand its leading Canadian position around the globe.”
Also from their materials, “Bedrocan is the epitome of medical-grade cannabis. Bedrocan BV pioneered medical cannabis in Holland through decades of selection and refinement, leading to standardized, whole bud cannabis strains that patients can rely on. Bedrocan Canada supplies the same standardized strains to the Canadian market through exclusive licensing rights to the American continents, an arrangement it will also enjoy for all future genetic advancements. Due to its consistency over time, Bedrocan’s strains have been used in clinical research in seven European countries. That commitment to research didn’t stay on the east side of the Atlantic – Bedrocan Canada recently launched one of the largest clinical cannabis studies in the world, the EQUAL Study, to evaluate quality of life before and after medical cannabis use.”
Find out when TWMJF stock reaches critical levels. Subscribe to FinanceRegistrar.com Right Now by entering your Email in the box below.
The US legal Marijuana sales grew by an unprecedented 30% in 2016 to $6.7 billion as the legal market expands in the U.S. and Canada, according to a new report by Arcview Market Research.
However, as stated above, TWMJF has global ambitions.
On September 21st, TWMJF announced it has established a binding strategic partnership in the emerging Danish market as part of its systematic expansion plan in Europe. Spectrum Denmark ApS (“Spectrum Denmark”) will be a joint venture between Canopy Growth and Danish Cannabis ApS (“Danish Cannabis”) which will serve the needs of Danish medical cannabis patients with Spectrum’s proven products.
Danish parliament recently passed legislation that paves the way for legal medicinal cannabis sales to begin January 1, 2018. To date, patient access to cannabis in Denmark has been limited to the sale of costly handmade compounds available from a single pharmacy.
CANOPY GROWTH CORP COM NPV (OTCMKTS:TWMJF) is expanding and has legitimate operations producing high-quality cannabis. This is a real McCoy in the cannabis space and well ahead of some contenders on the OTC. TWMJF is growing and the numbers back it up. We have covered this company extensively and we expect more from them before year end. Sign-up for continuing coverage on shares of $TWMJF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $TWMJF, either long or short, and we have not been compensated for this article.